 | • レポートコード：GIR201100568 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、アルツハイマー治療の世界市場を調査対象にし、アルツハイマー治療の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（メマンチン塩酸塩、ドネペジル塩酸塩、リバスチグミン、ガランタミン臭化水素酸塩）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Pfizer Inc、F. Hoffman Le Roche、Acadia Pharmaceuticals, Inc、Novartis International AG、Eli Lilly, Inc、Axovant Sciences Ltd、H. Lundbeck A/S、Astra Zeneca plc、Biotie Therapies、Merck & Co、Takeda Pharmaceutical Company Ltd ・メーカー別販売量、売上、市場シェア ・アルツハイマー治療の地域別市場分析 ・アルツハイマー治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・アルツハイマー治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・アルツハイマー治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・アルツハイマー治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・アルツハイマー治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・アルツハイマー治療の種類別市場規模2015-2020：メマンチン塩酸塩、ドネペジル塩酸塩、リバスチグミン、ガランタミン臭化水素酸塩 ・アルツハイマー治療の用途別市場規模2015-2020：病院、クリニック、その他 ・アルツハイマー治療の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Alzheimer’s Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Alzheimer’s Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Alzheimer’s Therapeutic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Alzheimer’s Therapeutic market has been segmented into
Memantine Hydrochloride
Donepezil Hydrochloride
Rivastigmine
Galantamine Hydrobromide
By Application, Alzheimer’s Therapeutic has been segmented into:
Hospitals
Clinic
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Alzheimer’s Therapeutic market presented in the report. This section sheds light on the sales growth of different regional and country-level Alzheimer’s Therapeutic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Alzheimer’s Therapeutic market.
The report offers in-depth assessment of the growth and other aspects of the Alzheimer’s Therapeutic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Alzheimer’s Therapeutic Market Share Analysis
Alzheimer’s Therapeutic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Alzheimer’s Therapeutic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Alzheimer’s Therapeutic sales, revenue and market share for each player covered in this report.
The major players covered in Alzheimer’s Therapeutic are:
Pfizer Inc
F. Hoffman Le Roche
Acadia Pharmaceuticals, Inc
Novartis International AG
Eli Lilly, Inc
Axovant Sciences Ltd
H. Lundbeck A/S
Astra Zeneca plc
Biotie Therapies
Merck & Co
Takeda Pharmaceutical Company Ltd
Among other players domestic and global, Alzheimer’s Therapeutic market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alzheimer’s Therapeutic product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alzheimer’s Therapeutic, with price, sales, revenue and global market share of Alzheimer’s Therapeutic in 2018 and 2019.
Chapter 3, the Alzheimer’s Therapeutic competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alzheimer’s Therapeutic breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Alzheimer’s Therapeutic market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Alzheimer’s Therapeutic sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Alzheimer’s Therapeutic Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Alzheimer’s Therapeutic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Memantine Hydrochloride
1.2.3 Donepezil Hydrochloride
1.2.4 Rivastigmine
1.2.5 Galantamine Hydrobromide
1.3 Market Analysis by Application
1.3.1 Overview: Global Alzheimer’s Therapeutic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Other
1.4 Overview of Global Alzheimer’s Therapeutic Market
1.4.1 Global Alzheimer’s Therapeutic Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer Inc
2.1.1 Pfizer Inc Details
2.1.2 Pfizer Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer Inc SWOT Analysis
2.1.4 Pfizer Inc Product and Services
2.1.5 Pfizer Inc Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 F. Hoffman Le Roche
2.2.1 F. Hoffman Le Roche Details
2.2.2 F. Hoffman Le Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 F. Hoffman Le Roche SWOT Analysis
2.2.4 F. Hoffman Le Roche Product and Services
2.2.5 F. Hoffman Le Roche Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Acadia Pharmaceuticals, Inc
2.3.1 Acadia Pharmaceuticals, Inc Details
2.3.2 Acadia Pharmaceuticals, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Acadia Pharmaceuticals, Inc SWOT Analysis
2.3.4 Acadia Pharmaceuticals, Inc Product and Services
2.3.5 Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis International AG
2.4.1 Novartis International AG Details
2.4.2 Novartis International AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis International AG SWOT Analysis
2.4.4 Novartis International AG Product and Services
2.4.5 Novartis International AG Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly, Inc
2.5.1 Eli Lilly, Inc Details
2.5.2 Eli Lilly, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly, Inc SWOT Analysis
2.5.4 Eli Lilly, Inc Product and Services
2.5.5 Eli Lilly, Inc Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Axovant Sciences Ltd
2.6.1 Axovant Sciences Ltd Details
2.6.2 Axovant Sciences Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Axovant Sciences Ltd SWOT Analysis
2.6.4 Axovant Sciences Ltd Product and Services
2.6.5 Axovant Sciences Ltd Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 H. Lundbeck A/S
2.7.1 H. Lundbeck A/S Details
2.7.2 H. Lundbeck A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 H. Lundbeck A/S SWOT Analysis
2.7.4 H. Lundbeck A/S Product and Services
2.7.5 H. Lundbeck A/S Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Astra Zeneca plc
2.8.1 Astra Zeneca plc Details
2.8.2 Astra Zeneca plc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Astra Zeneca plc SWOT Analysis
2.8.4 Astra Zeneca plc Product and Services
2.8.5 Astra Zeneca plc Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Biotie Therapies
2.9.1 Biotie Therapies Details
2.9.2 Biotie Therapies Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Biotie Therapies SWOT Analysis
2.9.4 Biotie Therapies Product and Services
2.9.5 Biotie Therapies Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Merck & Co
2.10.1 Merck & Co Details
2.10.2 Merck & Co Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Merck & Co SWOT Analysis
2.10.4 Merck & Co Product and Services
2.10.5 Merck & Co Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Takeda Pharmaceutical Company Ltd
2.11.1 Takeda Pharmaceutical Company Ltd Details
2.11.2 Takeda Pharmaceutical Company Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Takeda Pharmaceutical Company Ltd SWOT Analysis
2.11.4 Takeda Pharmaceutical Company Ltd Product and Services
2.11.5 Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Alzheimer’s Therapeutic Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Alzheimer’s Therapeutic Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Alzheimer’s Therapeutic Manufacturer Market Share in 2019
3.3.2 Top 6 Alzheimer’s Therapeutic Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Alzheimer’s Therapeutic Sales, Revenue and Market Share by Regions
4.1.1 Global Alzheimer’s Therapeutic Sales and Market Share by Regions (2015-2020)
4.1.2 Global Alzheimer’s Therapeutic Revenue and Market Share by Regions (2015-2020)
4.2 North America Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
4.3 Europe Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
4.5 South America Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Alzheimer’s Therapeutic Sales, Revenue and Market Share by Country
5.1.1 North America Alzheimer’s Therapeutic Sales and Market Share by Country (2015-2020)
5.1.2 North America Alzheimer’s Therapeutic Revenue and Market Share by Country (2015-2020)
5.2 United States Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
5.3 Canada Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
5.4 Mexico Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Alzheimer’s Therapeutic Sales, Revenue and Market Share by Country
6.1.1 Europe Alzheimer’s Therapeutic Sales and Market Share by Country (2015-2020)
6.1.2 Europe Alzheimer’s Therapeutic Revenue and Market Share by Country (2015-2020)
6.2 Germany Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
6.3 UK Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
6.4 France Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
6.5 Russia Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
6.6 Italy Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Alzheimer’s Therapeutic Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Alzheimer’s Therapeutic Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Alzheimer’s Therapeutic Revenue and Market Share by Regions (2015-2020)
7.2 China Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
7.3 Japan Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
7.4 Korea Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
7.5 India Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
7.7 Australia Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Alzheimer’s Therapeutic Sales, Revenue and Market Share by Country
8.1.1 South America Alzheimer’s Therapeutic Sales and Market Share by Country (2015-2020)
8.1.2 South America Alzheimer’s Therapeutic Revenue and Market Share by Country (2015-2020)
8.2 Brazil Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
8.3 Argentina Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Alzheimer’s Therapeutic Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Alzheimer’s Therapeutic Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Alzheimer’s Therapeutic Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
9.3 Turkey Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
9.4 Egypt Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
9.5 South Africa Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Alzheimer’s Therapeutic Sales and Market Share by Type (2015-2020)
10.2 Global Alzheimer’s Therapeutic Revenue and Market Share by Type (2015-2020)
10.3 Global Alzheimer’s Therapeutic Price by Type (2015-2020)
11 Global Alzheimer’s Therapeutic Market Segment by Application
11.1 Global Alzheimer’s Therapeutic Sales Market Share by Application (2015-2020)
11.2 Global Alzheimer’s Therapeutic Revenue Market Share by Application (2015-2020)
11.3 Global Alzheimer’s Therapeutic Price by Application (2015-2020)
12 Market Forecast
12.1 Global Alzheimer’s Therapeutic Sales, Revenue and Growth Rate (2021-2025)
12.2 Alzheimer’s Therapeutic Market Forecast by Regions (2021-2025)
12.2.1 North America Alzheimer’s Therapeutic Market Forecast (2021-2025)
12.2.2 Europe Alzheimer’s Therapeutic Market Forecast (2021-2025)
12.2.3 Asia-Pacific Alzheimer’s Therapeutic Market Forecast (2021-2025)
12.2.4 South America Alzheimer’s Therapeutic Market Forecast (2021-2025)
12.2.5 Middle East & Africa Alzheimer’s Therapeutic Market Forecast (2021-2025)
12.3 Alzheimer’s Therapeutic Market Forecast by Type (2021-2025)
12.3.1 Global Alzheimer’s Therapeutic Sales Forecast by Type (2021-2025)
12.3.2 Global Alzheimer’s Therapeutic Market Share Forecast by Type (2021-2025)
12.4 Alzheimer’s Therapeutic Market Forecast by Application (2021-2025)
12.4.1 Global Alzheimer’s Therapeutic Sales Forecast by Application (2021-2025)
12.4.2 Global Alzheimer’s Therapeutic Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Alzheimer’s Therapeutic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Alzheimer’s Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Alzheimer’s Therapeutic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Inc Alzheimer’s Therapeutic Major Business
Table 9. Pfizer Inc Alzheimer’s Therapeutic Total Revenue (USD Million) (2018-2019)
Table 10. Pfizer Inc SWOT Analysis
Table 11. Pfizer Inc Alzheimer’s Therapeutic Product and Services
Table 12. Pfizer Inc Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. F. Hoffman Le Roche Basic Information, Manufacturing Base and Competitors
Table 14. F. Hoffman Le Roche Alzheimer’s Therapeutic Major Business
Table 15. F. Hoffman Le Roche Alzheimer’s Therapeutic Total Revenue (USD Million) (2018-2019)
Table 16. F. Hoffman Le Roche SWOT Analysis
Table 17. F. Hoffman Le Roche Alzheimer’s Therapeutic Product and Services
Table 18. F. Hoffman Le Roche Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Acadia Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 20. Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Major Business
Table 21. Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Total Revenue (USD Million) (2018-2019)
Table 22. Acadia Pharmaceuticals, Inc SWOT Analysis
Table 23. Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Product and Services
Table 24. Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis International AG Basic Information, Manufacturing Base and Competitors
Table 26. Novartis International AG Alzheimer’s Therapeutic Major Business
Table 27. Novartis International AG Alzheimer’s Therapeutic Total Revenue (USD Million) (2018-2019)
Table 28. Novartis International AG SWOT Analysis
Table 29. Novartis International AG Alzheimer’s Therapeutic Product and Services
Table 30. Novartis International AG Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Eli Lilly, Inc Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly, Inc Alzheimer’s Therapeutic Major Business
Table 33. Eli Lilly, Inc Alzheimer’s Therapeutic Total Revenue (USD Million) (2018-2019)
Table 34. Eli Lilly, Inc SWOT Analysis
Table 35. Eli Lilly, Inc Alzheimer’s Therapeutic Product and Services
Table 36. Eli Lilly, Inc Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Axovant Sciences Ltd Basic Information, Manufacturing Base and Competitors
Table 38. Axovant Sciences Ltd Alzheimer’s Therapeutic Major Business
Table 39. Axovant Sciences Ltd Alzheimer’s Therapeutic Total Revenue (USD Million) (2018-2019)
Table 40. Axovant Sciences Ltd SWOT Analysis
Table 41. Axovant Sciences Ltd Alzheimer’s Therapeutic Product and Services
Table 42. Axovant Sciences Ltd Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. H. Lundbeck A/S Basic Information, Manufacturing Base and Competitors
Table 44. H. Lundbeck A/S Alzheimer’s Therapeutic Major Business
Table 45. H. Lundbeck A/S Alzheimer’s Therapeutic Total Revenue (USD Million) (2018-2019)
Table 46. H. Lundbeck A/S SWOT Analysis
Table 47. H. Lundbeck A/S Alzheimer’s Therapeutic Product and Services
Table 48. H. Lundbeck A/S Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Astra Zeneca plc Basic Information, Manufacturing Base and Competitors
Table 50. Astra Zeneca plc Alzheimer’s Therapeutic Major Business
Table 51. Astra Zeneca plc Alzheimer’s Therapeutic Total Revenue (USD Million) (2018-2019)
Table 52. Astra Zeneca plc SWOT Analysis
Table 53. Astra Zeneca plc Alzheimer’s Therapeutic Product and Services
Table 54. Astra Zeneca plc Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Biotie Therapies Basic Information, Manufacturing Base and Competitors
Table 56. Biotie Therapies Alzheimer’s Therapeutic Major Business
Table 57. Biotie Therapies Alzheimer’s Therapeutic Total Revenue (USD Million) (2018-2019)
Table 58. Biotie Therapies SWOT Analysis
Table 59. Biotie Therapies Alzheimer’s Therapeutic Product and Services
Table 60. Biotie Therapies Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Merck & Co Basic Information, Manufacturing Base and Competitors
Table 62. Merck & Co Alzheimer’s Therapeutic Major Business
Table 63. Merck & Co Alzheimer’s Therapeutic Total Revenue (USD Million) (2018-2019)
Table 64. Merck & Co SWOT Analysis
Table 65. Merck & Co Alzheimer’s Therapeutic Product and Services
Table 66. Merck & Co Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Takeda Pharmaceutical Company Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Major Business
Table 69. Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Total Revenue (USD Million) (2018-2019)
Table 70. Takeda Pharmaceutical Company Ltd SWOT Analysis
Table 71. Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Product and Services
Table 72. Takeda Pharmaceutical Company Ltd Alzheimer’s Therapeutic Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Alzheimer’s Therapeutic Sales by Manufacturer (2018-2019) (K Pcs)
Table 74. Global Alzheimer’s Therapeutic Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Alzheimer’s Therapeutic Sales by Regions (2015-2020) (K Pcs)
Table 76. Global Alzheimer’s Therapeutic Sales Market Share by Regions (2015-2020)
Table 77. Global Alzheimer’s Therapeutic Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Alzheimer’s Therapeutic Sales by Countries (2015-2020) (K Pcs)
Table 79. North America Alzheimer’s Therapeutic Sales Market Share by Countries (2015-2020)
Table 80. North America Alzheimer’s Therapeutic Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Alzheimer’s Therapeutic Revenue Market Share by Countries (2015-2020)
Table 82. Europe Alzheimer’s Therapeutic Sales by Countries (2015-2020) (K Pcs)
Table 83. Europe Alzheimer’s Therapeutic Sales Market Share by Countries (2015-2020)
Table 84. Europe Alzheimer’s Therapeutic Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Alzheimer’s Therapeutic Sales by Regions (2015-2020) (K Pcs)
Table 86. Asia-Pacific Alzheimer’s Therapeutic Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Alzheimer’s Therapeutic Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Alzheimer’s Therapeutic Sales by Countries (2015-2020) (K Pcs)
Table 89. South America Alzheimer’s Therapeutic Sales Market Share by Countries (2015-2020)
Table 90. South America Alzheimer’s Therapeutic Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Alzheimer’s Therapeutic Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Alzheimer’s Therapeutic Sales by Countries (2015-2020) (K Pcs)
Table 93. Middle East & Africa Alzheimer’s Therapeutic Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Alzheimer’s Therapeutic Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Alzheimer’s Therapeutic Revenue Market Share by Countries (2015-2020)
Table 96. Global Alzheimer’s Therapeutic Sales by Type (2015-2020) (K Pcs)
Table 97. Global Alzheimer’s Therapeutic Sales Share by Type (2015-2020)
Table 98. Global Alzheimer’s Therapeutic Revenue by Type (2015-2020) (USD Million)
Table 99. Global Alzheimer’s Therapeutic Revenue Share by Type (2015-2020)
Table 100. Global Alzheimer’s Therapeutic Sales by Application (2015-2020) (K Pcs)
Table 101. Global Alzheimer’s Therapeutic Sales Share by Application (2015-2020)
Table 102. Global Alzheimer’s Therapeutic Sales Forecast by Regions (2021-2025) (K Pcs)
Table 103. Global Alzheimer’s Therapeutic Market Share Forecast by Regions (2021-2025)
Table 104. Global Alzheimer’s Therapeutic Sales Forecast by Type (2021-2025) (K Pcs)
Table 105. Global Alzheimer’s Therapeutic Market Share Forecast by Type (2021-2025)
Table 106. Global Alzheimer’s Therapeutic Sales Forecast by Application (2021-2025)
Table 107. Global Alzheimer’s Therapeutic Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Alzheimer’s Therapeutic Picture
Figure 2. Global Sales Market Share of Alzheimer’s Therapeutic by Type in 2019
Figure 3. Memantine Hydrochloride Picture
Figure 4. Donepezil Hydrochloride Picture
Figure 5. Rivastigmine Picture
Figure 6. Galantamine Hydrobromide Picture
Figure 7. Alzheimer’s Therapeutic Sales Market Share by Application in 2018
Figure 8. Hospitals Picture
Figure 9. Clinic Picture
Figure 10. Other Picture
Figure 11. Global Alzheimer’s Therapeutic Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Alzheimer’s Therapeutic Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Alzheimer’s Therapeutic Sales Market Share by Manufacturer in 2019
Figure 32. Global Alzheimer’s Therapeutic Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Alzheimer’s Therapeutic Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Alzheimer’s Therapeutic Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 37. Global Alzheimer’s Therapeutic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Alzheimer’s Therapeutic Revenue Market Share by Regions (2015-2020)
Figure 39. Global Alzheimer’s Therapeutic Revenue Market Share by Regions in 2018
Figure 40. North America Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
Figure 41. Europe Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
Figure 43. South America Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020)
Figure 45. North America Alzheimer’s Therapeutic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Alzheimer’s Therapeutic Sales Market Share by Countries (2015-2020)
Figure 47. North America Alzheimer’s Therapeutic Sales Market Share by Countries in 2018
Figure 48. North America Alzheimer’s Therapeutic Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Alzheimer’s Therapeutic Revenue Market Share by Countries in 2018
Figure 50. United States Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Canada Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Mexico Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Europe Alzheimer’s Therapeutic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Alzheimer’s Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Alzheimer’s Therapeutic Revenue Market Share by Countries in 2019
Figure 56. Germany Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. UK Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. France Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Russia Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Italy Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Asia-Pacific Alzheimer’s Therapeutic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Alzheimer’s Therapeutic Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Alzheimer’s Therapeutic Revenue Market Share by Regions 2019
Figure 64. China Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Korea Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. India Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Southeast Asia Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. South America Alzheimer’s Therapeutic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Alzheimer’s Therapeutic Sales Market Share by Countries in 2019
Figure 71. South America Alzheimer’s Therapeutic Revenue Market Share by Countries in 2019
Figure 72. Brazil Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Argentina Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Middle East and Africa Alzheimer’s Therapeutic Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Alzheimer’s Therapeutic Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Alzheimer’s Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Alzheimer’s Therapeutic Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Egypt Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Turkey Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. South Africa Alzheimer’s Therapeutic Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Global Alzheimer’s Therapeutic Sales and Growth Rate (2021-2025) (K Pcs)
Figure 83. Global Alzheimer’s Therapeutic Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Alzheimer’s Therapeutic Market Forecast (2021-2025) (K Pcs)
Figure 85. Europe Sales Alzheimer’s Therapeutic Market Forecast (2021-2025) (K Pcs)
Figure 86. Asia-Pacific Sales Alzheimer’s Therapeutic Market Forecast (2021-2025) (K Pcs)
Figure 87. South America Sales Alzheimer’s Therapeutic Market Forecast (2021-2025) (K Pcs)
Figure 88. Middle East & Africa Sales Alzheimer’s Therapeutic Market Forecast (2021-2025) (K Pcs)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
アルツハイマー病治療薬の世界市場 2020年 Market Overview The Alzheimer's Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…- 弱視治療装置の世界市場 2020年 Market Overview The Amblyopia Therapeutic Apparatus market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 超音波治療器の世界市場 2020年 Market Overview The global Therapeutic Ultrasound Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Therapeutic Ul…
- 糖尿病性足潰瘍治療の世界市場 2020年 Market Overview The global Diabetic Foot Ulcer Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diabetic Foot…
- 衝撃波治療装置の世界市場 2020年 Market Overview The Shockwave Therapeutic Apparatus market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…